The Burden of Short-Acting Β2-Agonists Use in Asthma: Is There an Italian Case? An Update From SABINA Program
Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.
Verfasser: | |
---|---|
Dokumenttyp: | Dataset |
Erscheinungsdatum: | 2021 |
Schlagwörter: | Medicine / Respiratory Diseases / asthma / SABA consumption / guidelines recommendations / exacerbations / primary care / real world evidence |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-29243794 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.6084/m9.figshare.14519592.v1 |